683 Capital Management, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
683 Capital Management, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q1 2022$407,000
-4.9%
222,603
-26.7%
0.02%
+37.5%
Q4 2021$428,000
-89.0%
303,811
-84.8%
0.02%
-91.3%
Q4 2020$3,900,000
-18.4%
2,000,0000.0%0.18%
-47.4%
Q3 2020$4,780,000
-18.4%
2,000,0000.0%0.35%
-25.4%
Q2 2020$5,860,000
-49.1%
2,000,000
-50.0%
0.47%
-30.8%
Q1 2020$11,520,000
+311.4%
4,000,000
+471.4%
0.68%
+111.9%
Q4 2019$2,800,000
-55.8%
700,000
-50.9%
0.32%
-54.6%
Q3 2019$6,338,000
+15.0%
1,424,3780.0%0.70%
+40.7%
Q2 2019$5,512,000
+80.7%
1,424,378
+76.9%
0.50%
+80.9%
Q1 2019$3,051,000
+58.6%
805,0000.0%0.28%
+136.8%
Q4 2018$1,924,000
-61.5%
805,0000.0%0.12%
-63.9%
Q3 2018$4,999,000
+25.3%
805,000
-9.0%
0.32%
+20.0%
Q2 2018$3,991,000
+7.8%
885,000
+9.9%
0.27%
-17.4%
Q1 2018$3,703,000
+21.4%
805,000
-15.3%
0.33%
+27.2%
Q4 2017$3,050,000950,0000.26%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$13,240,00011.29%
Stonepine Capital Management, LLC 7,661,690$25,360,1948.50%
Altium Capital Management LP 2,870,000$9,499,7005.27%
Caligan Partners LP 1,662,613$5,503,2493.84%
AWM Investment Company, Inc. 6,015,000$19,909,6502.69%
Perceptive Advisors 11,900,255$39,389,8441.16%
EAM Investors, LLC 1,035,752$3,428,3390.67%
OBERWEIS ASSET MANAGEMENT INC/ 1,169,500$3,871,0450.60%
Magnetar Financial LLC 7,074,722$23,417,3300.46%
Virtus ETF Advisers LLC 83,925$277,7920.15%
View complete list of ADMA BIOLOGICS INC shareholders